Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus

BACKGROUND: The inhibitory CTLA-4 molecule is a crucial regulator of immune responses and a target for therapeutic intervention in both autoimmunity and cancer. In particular, CTLA-4 is important in controlling antigen-specific immunity, including responses to autoantigens associated with autoimmune...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Res Ther
Asıl Yazarlar: Dahal, Lekh N., Basu, Neil, Youssef, Hazem, Khanolkar, Rahul C., Barker, Robert N., Erwig, Lars P., Ward, Frank J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4973056/
https://ncbi.nlm.nih.gov/pubmed/27487771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1075-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller